XTL BioPharma
XTLB1.9602.62% ( +0.050 )
XTL BioPharma (XTLB)
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune dis...
- Open
- 1.940
- High
- 2.013
- Low
- 1.940
- Prev. Close
- 1.910
- Volume
- 1.53K
- Turnover
- 3.02K
- Avg Price
- 1.973
- Bid/Ask Ratio
- --
- Amplitude
- 3.82%
- 52wk High
- 5.960
- Volume Ratio
- 0.41
- Turnover Ratio
- 0.06%
- 52wk Low
- 1.860
- Float Mkt Cap
- 4.62M
- Market CapUSD
- 6.49M
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -2.10
- EPSDynamic
- -2.10
- EPSStatic
- --
- BVPS
- -0.08
- P/B
- --
- Circulating Supply
- 2.36M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 3.31M
- Min lot size
- 1
- Currency
- USD
News
- PUBT ·
XTL Biopharmaceuticals Nominates Gilai Dolev as External Director
- Weekly Review ·
Weekly Recap | XTL BioPharma +2.43%, ahead of the S&P 500
- Global Report ·
Fed Signals and Sector Shifts: The Balancing Act in Financial Holdings
- PUBT ·
XTL Biopharma faces shareholder bid for derivative suit seeking NIS 100 million damages
- Tip Ranks ·
XTL Biopharmaceuticals Faces Derivative Action Bid Over Failed Social Proxy Acquisition
